Hjem › Astrocytom › Ohio › Cincinnati
Astrocytom kliniske forsøg i Cincinnati, OH
5 studier for Astrocytom søger deltagere på steder i og omkring Cincinnati (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RekruttererFase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi væk
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservationsstudie
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Astrocytom forsøg i andre byer
- Houston, TX14 studier
- Boston, MA13 studier
- Chicago, IL9 studier
- New York City, NY9 studier
- Miami, FL7 studier
- Philadelphia, PA7 studier
- Washington, DC6 studier
- Durham, NC6 studier
- Seattle, WA6 studier
- Columbus, OH6 studier
- San Francisco, CA6 studier
- Aurora, CO5 studier
Andre studier i Cincinnati
- Ikke-småcellet lungecancer35 studier
- Kræft (alle typer)27 studier
- Brystkræft25 studier
- Hjertesvigt24 studier
- Colorektal kræft21 studier
- Akut myeloid leukæmi20 studier
- Metastatisk cancer20 studier
- Ægstockræft19 studier
- Lungecancer19 studier
- Overvægt19 studier
- Prostatakræft18 studier
- Multipelt myelom17 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.